Stocks in play: Ventripoint Diagnostics Ltd.

Has successfully completed the Medical Device Single Audit Program re-certification for its Quality Management System under ISO 13485:2016 regulations and the FDA Quality System Regulations, which facilitates continued design, manufacturing, installation and servicing of its products in Canada and the United States. Ventripoint Diagnostics Ltd. shares V.VPT are trading down $0.005 at $0.34.

Read:

• As Crypto Mining Undergoes a Sustainable Renaissance, Newer, Greener Operations Arise

• Oncology Drug Developers Looking at Significant Projected Growth Through 2030

• Plant-Based Meats Continue to Sprout Growing Revenues on Year-Over-Year Basis

• No Apparent Need to Panic Over Omicron as Vaccine Developers Are on the Case

• Plant-Based Meats Market Projected to Hit $162 Billion by 2030, as New Products Launch